Rua Bioscience Limited (NZE:RUA)

Market Cap	9.16M +4.3%
Revenue (ttm)	2.81M +53.9%
Net Income	-3.36M
EPS	-0.01
Shares Out	339.44M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	17,964
Open	0.0270
Previous Close	0.0280
Day's Range	0.0270 - 0.0270
52-Week Range	0.0260 - 0.0430
Beta	0.52
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 27, 2026

About Rua Bioscience

Rua Bioscience Limited engages in the research, development, and sale of pharmaceutical products in New Zealand and internationally. It offers cannabis-derived medicines. The company is also involved in plant research, genetic discovery, seed production, and breeding development related activities. Rua Bioscience Limited was formerly known as Hikurangi Cannabis Company Limited and changed its name to Rua Bioscience Limited in October 2019. The company was founded in 2016 and is based in Ruatoria, New Zealand.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2016
• Employees: 30
• Stock Exchange: New Zealand Stock Exchange
• Ticker Symbol: RUA

Financial Performance

In fiscal year 2026, Rua Bioscience's revenue was 2.81 million, an increase of 53.88% compared to the previous year's 1.83 million. Losses were -3.36 million, -2.78% less than in 2025.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 2, 2026

Data Sources Report a data error